These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 284212)

  • 1. L-dopa and hepatic encephalopathy.
    Loiudice TA; Tulman A; Buhac I
    N Y State J Med; 1979 Mar; 79(3):364-6. PubMed ID: 284212
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 4. Arousal response in hepatic encephalopathy with L-Dopa.
    Weiss A; Pitman ER; Javdan P
    Am J Gastroenterol; 1974 Dec; 62(6):497-503. PubMed ID: 4447098
    [No Abstract]   [Full Text] [Related]  

  • 5. Levodopa in the treatment of hepatic coma due to fulminant hepatic failure.
    Mehta JM; Karamarkar SG; Pimparkar BD; Sheth UK
    J Postgrad Med; 1976 Jan; 22(1):32-6. PubMed ID: 966185
    [No Abstract]   [Full Text] [Related]  

  • 6. Memantine for Behavioral Symptoms of Hepatic Encephalopathy Associated With Alcoholic Cirrhosis: A Case Report.
    Ichinose M; Miura I; Horikoshi S; Matsumoto J; Osakabe Y; Yabe H
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):85-86. PubMed ID: 33298741
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa and benserazide in the treatment of acute hepatic encephalopathy in infancy.
    Sinniah D; Chan LL
    Singapore Med J; 1980 Aug; 21(4):658-60. PubMed ID: 7221579
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic encephalopathy].
    Rózga J; Szczerbań J
    Pol Tyg Lek; 1980 Jan; 35(4):117-20. PubMed ID: 7053045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 10. [Editorial: L-dopa in the treatment of hepatic coma].
    Douer D; Pinkhas I
    Harefuah; 1974 Sep; 87(6):269-71. PubMed ID: 4442803
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of acute hepatic coma to L-dopa [proceedings].
    Funovics JM; Wesdorp RI; Falcão HA; Fischer JE
    Rev Gastroenterol Mex; 1975; 40(5):290-1. PubMed ID: 1236396
    [No Abstract]   [Full Text] [Related]  

  • 13. Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy.
    Carrión JA; Bellot P; Colmenero J; Garcia Pagan JC
    J Hepatol; 2004 May; 40(5):868. PubMed ID: 15094238
    [No Abstract]   [Full Text] [Related]  

  • 14. [2 cases of metabolic acidosis during therapy of portosystemic encephalopathy with branched-chain amino acids].
    Gambelli F; Antoniazzi V; Meregalli M; Torchio G
    Minerva Med; 1986 Mar; 77(9-10):321-2. PubMed ID: 3951734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic encephalopathy. Rifaximin opens new perspectives].
    MMW Fortschr Med; 2014 Jul; 156(13):78-9. PubMed ID: 25318235
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of 1-dopa in hepatic coma].
    Cohen L; Kitzes-Cohen R; Rosenfeld J
    Harefuah; 1977 Mar; 92(5):209-10. PubMed ID: 852756
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
    Baldy-Moulinier M; Bories P; Michel H; Passouant P
    Rev Neurol (Paris); 1977 Mar; 133(3):175-89. PubMed ID: 918461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.